SOST and osteoporosis: To fill the current gap, the following research is needed: To further clarify the specific mechanism of sclerostin in diabetes-induced osteoporosis, remove obstacles for clinical study; To develop safe and effective sclerostin inhibitors, prevent and treat osteoporosis induced by diabetes is warranted.